JP2021525083A5 - - Google Patents
Info
- Publication number
- JP2021525083A5 JP2021525083A5 JP2020565415A JP2020565415A JP2021525083A5 JP 2021525083 A5 JP2021525083 A5 JP 2021525083A5 JP 2020565415 A JP2020565415 A JP 2020565415A JP 2020565415 A JP2020565415 A JP 2020565415A JP 2021525083 A5 JP2021525083 A5 JP 2021525083A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sodium phosphate
- methionine
- sucrose
- composition according
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024039768A JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862676525P | 2018-05-25 | 2018-05-25 | |
| US62/676,525 | 2018-05-25 | ||
| PCT/US2019/033983 WO2019227029A1 (en) | 2018-05-25 | 2019-05-24 | Pharmaceutical compositions for treating acid sphingomyelinase deficiency |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024039768A Division JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021525083A JP2021525083A (ja) | 2021-09-24 |
| JPWO2019227029A5 JPWO2019227029A5 (https=) | 2022-05-26 |
| JP2021525083A5 true JP2021525083A5 (https=) | 2022-05-26 |
| JP7497300B2 JP7497300B2 (ja) | 2024-06-10 |
Family
ID=66912954
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565415A Active JP7497300B2 (ja) | 2018-05-25 | 2019-05-24 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
| JP2024039768A Active JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024039768A Active JP7832245B2 (ja) | 2018-05-25 | 2024-03-14 | 酸性スフィンゴミエリナーゼ欠損症を治療するための医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210145941A1 (https=) |
| EP (1) | EP3802805A1 (https=) |
| JP (2) | JP7497300B2 (https=) |
| KR (1) | KR102852946B1 (https=) |
| CN (1) | CN112424347A (https=) |
| AU (2) | AU2019275109C1 (https=) |
| BR (1) | BR112020023829A2 (https=) |
| CA (1) | CA3101688A1 (https=) |
| CO (1) | CO2020014399A2 (https=) |
| IL (1) | IL278964A (https=) |
| MX (2) | MX2020012700A (https=) |
| PY (1) | PY1939780A (https=) |
| SG (1) | SG11202011488WA (https=) |
| UY (1) | UY38238A (https=) |
| WO (1) | WO2019227029A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024506860A (ja) * | 2021-02-01 | 2024-02-15 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | ニーマンピック病ａ型を治療するための組成物及び方法 |
| TW202403043A (zh) | 2022-03-18 | 2024-01-16 | 美商健臻公司 | 重組人類酸性鞘磷脂酶醫藥組合物及方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5773278A (en) | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
| ES2351786T3 (es) * | 2001-11-13 | 2011-02-10 | Genentech, Inc. | Formulaciones con ligando apo2/trail y usos de las mismas. |
| WO2004112826A1 (en) | 2003-06-20 | 2004-12-29 | Ares Trading Sa | Freeze-dried fsh / lh formulations |
| JP2007514661A (ja) * | 2003-11-25 | 2007-06-07 | マウント シナイ スクール オブ メディスン オブ ニューヨーク ユニバーシティー | ニーマンピック病のシャペロンに基づく治療方法 |
| AR059089A1 (es) | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal |
| HRP20120994T1 (hr) | 2006-02-07 | 2012-12-31 | Shire Human Genetic Therapies, Inc. | Stabilizirana smjesa glukocerebrozidaze |
| MX2008011842A (es) * | 2006-03-13 | 2008-10-02 | Encysive Pharmaceuticals Inc | Procedimientos y composiciones para el tratamiento de insuficiencia cardiaca diastolica. |
| CN102943106A (zh) * | 2006-03-13 | 2013-02-27 | 珀金埃尔默健康科学股份有限公司 | 用于质谱法检测的底物和内标 |
| AU2010263058A1 (en) | 2009-06-18 | 2012-01-12 | Wyeth Llc | Lyophilized formulations for small modular immunopharmaceuticals |
| SI3998078T1 (sl) | 2009-08-28 | 2026-02-27 | Genzyme Corporation | Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze |
| NZ605874A (en) | 2010-06-25 | 2015-02-27 | Shire Human Genetic Therapies | Methods and compositions for cns delivery of heparan n-sulfatase |
| WO2012134240A2 (ko) * | 2011-03-31 | 2012-10-04 | (주)메디톡스 | 보툴리눔 독소의 동결건조제제 |
| JP6480154B2 (ja) | 2014-11-06 | 2019-03-06 | 持田製薬株式会社 | エタネルセプトの凍結乾燥製剤 |
| FI126979B (en) * | 2016-02-29 | 2017-09-15 | Faron Pharmaceuticals Oy | Lyophilized pharmaceutical formulation and its use |
| KR20250025051A (ko) * | 2017-08-24 | 2025-02-20 | 사노피 | 산성 스핑고미엘린분해효소 결핍증 환자에서의 비정상적 골병태의 치료 |
-
2019
- 2019-05-23 PY PY201901939780A patent/PY1939780A/es unknown
- 2019-05-23 UY UY0001038238A patent/UY38238A/es not_active Application Discontinuation
- 2019-05-24 CN CN201980048133.7A patent/CN112424347A/zh active Pending
- 2019-05-24 MX MX2020012700A patent/MX2020012700A/es unknown
- 2019-05-24 WO PCT/US2019/033983 patent/WO2019227029A1/en not_active Ceased
- 2019-05-24 SG SG11202011488WA patent/SG11202011488WA/en unknown
- 2019-05-24 EP EP19731419.8A patent/EP3802805A1/en active Pending
- 2019-05-24 AU AU2019275109A patent/AU2019275109C1/en active Active
- 2019-05-24 JP JP2020565415A patent/JP7497300B2/ja active Active
- 2019-05-24 KR KR1020207037328A patent/KR102852946B1/ko active Active
- 2019-05-24 CA CA3101688A patent/CA3101688A1/en active Pending
- 2019-05-24 BR BR112020023829-5A patent/BR112020023829A2/pt unknown
-
2020
- 2020-11-20 CO CONC2020/0014399A patent/CO2020014399A2/es unknown
- 2020-11-25 IL IL278964A patent/IL278964A/en unknown
- 2020-11-25 US US17/104,593 patent/US20210145941A1/en active Pending
- 2020-11-25 MX MX2025002733A patent/MX2025002733A/es unknown
-
2024
- 2024-03-14 JP JP2024039768A patent/JP7832245B2/ja active Active
-
2025
- 2025-07-17 AU AU2025205577A patent/AU2025205577A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012523414A5 (https=) | ||
| Ropper et al. | Limited relapse in Guillain-Barré syndrome after plasma exchange | |
| CN102643339B (zh) | 一种glp-1类似物、制备方法及其应用 | |
| JP2024069459A5 (https=) | ||
| JP2019533722A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2021525083A5 (https=) | ||
| JP2010501596A5 (https=) | ||
| RU2018132639A (ru) | Терапевтические слитые белки направленного действия на основе лизосомных ферментов, соответствующие составы и их применения | |
| JP2015527125A5 (https=) | ||
| JP2005506275A5 (https=) | ||
| JPH06503319A (ja) | 細胞増殖マトリックス及びその用法 | |
| JP2020509052A5 (https=) | ||
| CN104940994B (zh) | 一种人造鼻粘膜及其用途 | |
| JPWO2019227029A5 (https=) | ||
| CN1160123C (zh) | 乌司他丁用于治疗严重急性呼吸综合征的用途及其药物组合物 | |
| RU2024125372A (ru) | Фармацевтические композиции для лечения недостаточности кислой сфингомиелиназы | |
| JP4630931B2 (ja) | 消化管溶性剤型 | |
| US20040116521A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
| CN118831041A (zh) | 一种纳米酶凝胶及其制备方法和应用 | |
| EP4477223A4 (en) | A pharmaceutical composition comprising allopurinol, febuxostat, or a pharmaceutically acceptable salt, combined for the prevention or treatment of chronic nephropathy in a patient with elevated blood uric acid levels. | |
| JP2014512369A5 (https=) | ||
| CN103923208B (zh) | 一种重组人角质细胞生长因子-2突变体的活性稳定剂 | |
| CN104208189A (zh) | 治疗复发性口腔溃疡的中药制剂 | |
| AU2002229678B2 (en) | Ribavirin granulate for producing coated tablets |